1980
DOI: 10.1001/archderm.116.2.186
|View full text |Cite
|
Sign up to set email alerts
|

Percutaneous absorption of hydrocortisone increases with long-term administration. In vivo studies in the rhesus monkey

Abstract: This study compares percutaneous absorption of hydrocortisone after short and long-term administration. The experimental design was to first apply 14C-hydrocortisone. This was followed by long-term administration of nonradioactive hydrocortisone. Then 14C-hydrocortisone was applied again when urinary excretion of radioactivity from the first application reached minimum detectable levels. Short- (first 14C-hydrocortisone application) and long-term (second 14C-hydrocortisone application) penetrations were compar… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

1983
1983
2009
2009

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 13 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…Over 1.5 million prescriptions are written each year in Australia for topical potent corticosteroids such as betamethasone, dexamethasone, and triamcinolone, some of which are used by pregnant women. Unless they also contain aminoglycosides, the pregnancy category for these preparations is “A”: “drugs which have been taken by a large number of pregnant women and women of child‐bearing age without any proven increase in the frequency of malformations or other direct or indirect harmful effects on the fetus having been observed.” Systemic absorption depends on the type and dosage of preparation used and the nature and extent of the underlying skin condition, but it can be significant, especially with repeated applications [Mizuchi et al, 1976; Schaefer et al, 1977; Wester et al, 1980; Turpeinen, 1991; Barnetson and White, 1992; Melendres et al, 1992].…”
Section: Introductionmentioning
confidence: 99%
“…Over 1.5 million prescriptions are written each year in Australia for topical potent corticosteroids such as betamethasone, dexamethasone, and triamcinolone, some of which are used by pregnant women. Unless they also contain aminoglycosides, the pregnancy category for these preparations is “A”: “drugs which have been taken by a large number of pregnant women and women of child‐bearing age without any proven increase in the frequency of malformations or other direct or indirect harmful effects on the fetus having been observed.” Systemic absorption depends on the type and dosage of preparation used and the nature and extent of the underlying skin condition, but it can be significant, especially with repeated applications [Mizuchi et al, 1976; Schaefer et al, 1977; Wester et al, 1980; Turpeinen, 1991; Barnetson and White, 1992; Melendres et al, 1992].…”
Section: Introductionmentioning
confidence: 99%
“…The exception is when the penetrant itself alters the barrier function of the skin, altering the absorption from subsequent applications, as demonstrated by hydrocortisone and salicylic acid. As shown with hydrocortisone, chronic administration resulted in signifi cant enhancement of penetration (Wester et al, 1980a) as a consequence of hydrocortisone-induced thinning of the skin. Changes to local skin histology and function were also attributed to increased fl ux across rat skin following chronic administration of the keratolytic agent, salicylic acid (Roberts and Harlock, 1978).…”
Section: Factors Aff Ecting Exposure and Absorptionmentioning
confidence: 88%
“…All subsequent urinary output was collected as pooled specimens for each subject at approxi¬ mately 4,8,12,36 Analysis of fecal excretion of radioactivity was performed for three subjects from the 1% minoxidil group and three from the 5% minoxidil group. Since no radioactivity could be detected in the fecal sam¬ ples of these six subjects, fecal samples from the remainder of the group were not analyzed.…”
Section: Clinical Evaluationmentioning
confidence: 99%